1. Home
  2. SRPT vs EVGOW Comparison

SRPT vs EVGOW Comparison

Compare SRPT & EVGOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • EVGOW
  • Stock Information
  • Founded
  • SRPT 1980
  • EVGOW 2010
  • Country
  • SRPT United States
  • EVGOW United States
  • Employees
  • SRPT N/A
  • EVGOW 331
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • EVGOW Other Specialty Stores
  • Sector
  • SRPT Health Care
  • EVGOW Consumer Discretionary
  • Exchange
  • SRPT Nasdaq
  • EVGOW Nasdaq
  • Market Cap
  • SRPT 1.7B
  • EVGOW N/A
  • IPO Year
  • SRPT 1997
  • EVGOW N/A
  • Fundamental
  • Price
  • SRPT $17.97
  • EVGOW $0.20
  • Analyst Decision
  • SRPT Buy
  • EVGOW
  • Analyst Count
  • SRPT 25
  • EVGOW 0
  • Target Price
  • SRPT $61.57
  • EVGOW N/A
  • AVG Volume (30 Days)
  • SRPT 7.9M
  • EVGOW 74.7K
  • Earning Date
  • SRPT 08-06-2025
  • EVGOW 03-07-2025
  • Dividend Yield
  • SRPT N/A
  • EVGOW N/A
  • EPS Growth
  • SRPT N/A
  • EVGOW N/A
  • EPS
  • SRPT N/A
  • EVGOW N/A
  • Revenue
  • SRPT $2,233,371,000.00
  • EVGOW $239,306,000.00
  • Revenue This Year
  • SRPT $26.87
  • EVGOW N/A
  • Revenue Next Year
  • SRPT $3.15
  • EVGOW N/A
  • P/E Ratio
  • SRPT N/A
  • EVGOW N/A
  • Revenue Growth
  • SRPT 59.15
  • EVGOW 73.08
  • 52 Week Low
  • SRPT $16.88
  • EVGOW $0.12
  • 52 Week High
  • SRPT $154.13
  • EVGOW $1.99
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 28.43
  • EVGOW 40.24
  • Support Level
  • SRPT $17.31
  • EVGOW $0.19
  • Resistance Level
  • SRPT $19.74
  • EVGOW $0.22
  • Average True Range (ATR)
  • SRPT 1.04
  • EVGOW 0.02
  • MACD
  • SRPT 0.87
  • EVGOW -0.00
  • Stochastic Oscillator
  • SRPT 45.83
  • EVGOW 37.38

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About EVGOW EVgo Inc.

EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.

Share on Social Networks: